Global quality pharmacopoeia published by the World Health Organization
The International Pharmacopoeia (Pharmacopoeia Internationalis, Ph. Int.) is a pharmacopoeia issued by the World Health Organization[1] as a recommendation, with the aim to provide international quality specifications for pharmaceutical substances (active ingredients and excipients) and dosage forms,[2] together with supporting general methods of analysis, for global use. Its texts can be used or adapted by any WHO member state wishing to establish legal pharmaceutical requirements.[2]
The Ph.Int. is based primarily on medicines included in the current WHO Model List of Essential Medicines (EML) and medicines included in the current invitations to manufacturers to submit an expression of interest (EOI) to the WHO Prequalification Team – Medicines (PQT) and those of interest to other UN Organizations. In recent years, priority has been given to medicines of importance in low and middle income countries, which may not appear in any other pharmacopoeias, including child-friendly dosage forms.
The Ph.Int. is designed to serve all Member States, especially their national and regional regulatory authorities, organizations in the United Nations system, and regional and interregional harmonization efforts, and they underpin important public health initiatives, including the prequalification and procurement of quality medicines through major international entities, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, and UNICEF.
The monographs published in the Ph.Int. are established in an independent manner via a consultative procedure and based on international experience.[3]
Monographs on radiopharmaceuticals developed with the International Atomic Energy Agency.
^WHO (2018), The International Pharmacopoeia (8th ed.), archived from the original on 2011-07-09, retrieved 2015-10-16.
^ abHill, Melissa Sue, ed. (2017). "The World Health Organization (WHO)". Worldmark Encyclopedia of the Nations. Farmington Hills, MI: Gale.
^"Procedure for the development of monographs and other texts for The International Pharmacopoeia" (PDF). Archived (PDF) from the original on 2020-08-26. Retrieved 2022-02-26.
and 26 Related for: The International Pharmacopoeia information
TheInternationalPharmacopoeia (Pharmacopoeia Internationalis, Ph. Int.) is a pharmacopoeia issued by the World Health Organization as a recommendation...
A pharmacopoeia, pharmacopeia, or pharmacopoea (from the obsolete typography pharmacopœia, meaning "drug-making"), in its modern technical sense, is a...
The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom. It is an annually published collection of quality standards for medicinal...
The European Pharmacopoeia (Pharmacopoeia Europaea, Ph. Eur.) is a major regional pharmacopoeia which provides common quality standards throughout the...
Pharmacopoeia European Pharmacopoeia Japanese PharmacopoeiaPharmacopoeia of the People's Republic of China TheInternationalPharmacopoeia National formulary...
The Japanese Pharmacopoeia (日本薬局方) is the official pharmacopoeia of Japan. It is published by the Pharmaceuticals and Medical Devices Agency (独立行政法人 医薬品医療機器総合機構...
medicines from theinternationalpharmacopoeia. Between 1952 and 1960, another WHO committee emitted repeated negative conclusions regarding the therapeutic...
such as the European Pharmacopoeia and theInternationalPharmacopoeia of the World Health Organization (WHO), have been the next level. In 1953 the WHO created...
monograph in TheInternationalPharmacopoeia" (PDF). who.int. Retrieved 5 June 2018. Note: As of June 2018, doxycycline hyclate is apparently the only known...
specific rotation" (PDF). TheInternationalPharmacopoeia. World Health Organization. 2017. ISBN 9789241550031. Archived (PDF) from the original on 2022-10-09...
Pharmacopeia. 2003. Archived from the original on 3 January 2013. InternationalPharmacopoeia 2006. World Health Organization. 2006. pp. 966. ISBN 978-92-4-156301-7...
Pharmacopoeia Volume III. British Pharmacopoeia. 2013. Archived from the original on 2017-08-15. InternationalPharmacopoeia 2006. World Health Organization...
TheInternationalPharmacopoeia, p.1292, Volume 1, World Health Organization, 2006 ISBN 92-4-156301-X. N G Coley, "The collateral sciences in the work...
Mandate The World Health Organization has a constitutional mandate to "develop, establish and promote international standards with respect to biological...
abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes). This list does...
leaves (Rhus coriaria). According to the definitions provided in external references such as internationalpharmacopoeia, Food Chemicals Codex and FAO-WHO...
particulates from reaching the wearer's nose and mouth. medical grade oxygen medical oxygen TheInternationalPharmacopoeia specifies that Medical oxygen...
P. Singh Baghel . Since 1955 the Ministry regularly publishes the Indian Pharmacopoeia through the Indian Pharmacopoeia Commission (IPC), an autonomous...
is one a child can avoid." British Pharmacopoeia European Pharmacopoeia Food Chemicals Codex Japanese Pharmacopoeia United States Pharmacopeia Acceptable...
introduced by the publication of the London Pharmacopoeia of 1836, the Edinburgh Pharmacopoeia of 1839, and the Dublin Pharmacopoeia of 1850. The Medical Act...
States Pharmacopoeia (USP), European Pharmacopoeia (Ph.Eur), or for the CAS number. Instead of requiring bituminous schists like these definitions, the Chinese...
thiopentone Infusion can cause fixed dilated pupils TheInternationalPharmacopoeia Foldes FF (1954). "The Mode of Action of Quaternary Ammonium Type Neuromuscular...
Welfare, Japan National pharmaceuticals policy Pharmaceutical policy Pharmacopoeia Pharmaceutical Research and Manufacturers of America Pharmaceuticals...
the official, non-proprietary, or generic name given to a pharmaceutical substance, as defined in the British Pharmacopoeia (BP). The BAN is also the...